Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 3/20 | 0.75 |
| ▸ | MEN1 | O00255 | 10/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 10/20 | 0.68 |
| ▸ | KDM4E | B2RXH2 | 10/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 10/20 | 0.68 |
| ▸ | MAPT | P10636 | 9/20 | 0.68 |
| ▸ | HPGD | P15428 | 5/20 | 0.68 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.68 |
| ▸ | ATM | Q13315 | 6/20 | 0.66 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.66 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.66 |
| ▸ | MAOB | P27338 | 3/20 | 0.66 |
| ▸ | USP2 | O75604 | 3/20 | 0.66 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.66 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.66 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.66 |
| ▸ | SLC16A3 | O15427 | 1/20 | 0.66 |
| ▸ | SLC16A1 | P53985 | 1/20 | 0.66 |
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.65 |
| ▸ | GLA | P06280 | 2/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16284305 | 0.88 | ALDH1A1 (0.61) | CYP19A1MEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL2030045 | 0.84 | CYP19A1 (0.75) | CYP19A1MEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL13067106 | 0.84 | CYP19A1 (0.75) | CYP19A1MEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL28447904 | 0.83 | CYP19A1 (0.73) | CYP19A1MEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL3546791 | 0.83 | CYP19A1 (0.73) | CYP19A1MEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL24589994 | 0.83 | CYP19A1 (0.73) | CYP19A1MEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL28712885 | 0.83 | CYP19A1 (0.73) | CYP19A1MEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL28089750 | 0.83 | CYP19A1 (0.73) | CYP19A1MEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL25842366 | 0.82 | SLC16A3 (0.63) | CYP19A1MEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL13869506 | 0.82 | CYP19A1 (0.86) | CYP19A1MEN1KMT2AKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4402236-A1 | LAUNDRY COMPOSITION FOR THE REMOVAL OF STAINS | Reckitt Benckiser Vanish B.V. (NL) | 2024-07-24 | — | — | EP | disclosed |
| WO-2024073568-A2 | EVOLUTION OF FLUOROGENIC SENSORS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2024-04-04 | — | — | WO | disclosed |
| WO-2023041739-A1 | LAUNDRY COMPOSITION FOR THE REMOVAL OF STAINS | RECKITT BENCKISER VANISH B.V. (NL) | 2023-03-23 | — | — | WO | disclosed |
| US-11174281-B1 | Modified nucleotides and uses thereof | Singular Genomics Systems, Inc. (US) | 2021-11-16 | — | — | US | disclosed |
| WO-2021216998-A1 | MODIFIED NUCLEOTIDES AND USES THEREOF | Singular Genomics Systems, Inc. (US) | 2021-10-28 | — | — | WO | disclosed |
| US-20210300937-A1 | Novel Labelled Cannabinergic Ligands and Related Analogs | MAKRIYANNIS ALEXANDROS (US) | 2021-09-30 | — | — | US | disclosed |
| EP-3863550-A1 | METHODS, DEVICES, AND COMPOSITIONS FOR MEASURING AND INDUCING CELL-TO-CELL COMMUNICATION, AND THERAPEUTIC USES THEREOF | Immunolight, Llc. (US) | 2021-08-18 | — | — | EP | disclosed |
| WO-2020193765-A1 | METHODS AND COMPOSITIONS FOR NUCLEIC ACID SEQUENCING USING PHOTOSWITCHABLE LABELS | ILLUMINA CAMBRIDGE LIMITED (GB) | 2020-10-01 | — | — | WO | disclosed |
| US-10745393-B2 | Small molecular probes, processes and use thereof | JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH (IN) | 2020-08-18 | — | — | US | disclosed |
| WO-2020058339-A1 | COUMARIN-BASED CROSSLINKING REAGENTS | VENTANA MEDICAL SYSTEMS, INC. (US) | 2020-03-26 | — | — | WO | disclosed |
| WO-2002046252-A1 | IRRADIATION CURABLE, HIGH SOLID COATING COMPOSITIONS AND THEIR PREPARATION | RESOLUTION RESEARCH NEDERLAND B.V. (NL) | 2002-06-13 | — | — | WO | disclosed |
| EP-0489836-B1 | LIGHT ACTIVATED ACYL-ENZYMES | UNIV DUKE (US) | 1994-12-21 | — | — | EP | disclosed |
| EP-0260823-B1 | IMPROVEMENTS IN OR RELATING TO PRINTING PLATE PRECURSORS | E.I. du Pont de Nemours and Company (US) | 1993-06-09 | — | — | EP | disclosed |
| US-5218137-A | Chemical light amplifiers | DUKE UNIVERSITY (US) | 1993-06-08 | — | — | US | disclosed |
| EP-0489836-A4 | LIGHT ACTIVATED ACYL-ENZYMES | — | 1993-05-26 | — | — | EP | disclosed |
| EP-0489836-A1 | LIGHT ACTIVATED ACYL-ENZYMES. | UNIV DUKE (US) | 1992-06-17 | — | — | EP | disclosed |
| US-5114851-A | Serine- or cysteine-containing protease modified by nucleophilic cinnamic acid; photoisomerization; biological switches; medical diagnosis | DUKE UNIVERSITY (US) | 1992-05-19 | — | — | US | disclosed |
| WO-1991003549-A1 | LIGHT ACTIVATED ACYL-ENZYMES | DUKE UNIVERSITY (US) | 1991-03-21 | — | — | WO | disclosed |
| US-4999271-A | Photopolymerizable urethane acrylate or methacrylate, lithography | VICKERS PLC (GB) | 1991-03-12 | — | — | US | disclosed |
| EP-0260823-A2 | Improvements in or relating to printing plate precursors | E.I. du Pont de Nemours and Company (US) | 1988-03-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10745393-B2 | Small molecular probes, processes and use thereof | APBA1, APP, PRNP | CYP19A1 4687/4885MEN1 1123/4885KMT2A 3252/4885 |
| US-11174281-B1 | Modified nucleotides and uses thereof | NUDT1, RNMT, ADAR | CYP19A1 3552/4885MEN1 2915/4885KMT2A 1548/4885 |
| US-20210300937-A1 | Novel Labelled Cannabinergic Ligands and Related Analogs | CNR1, CNR2, CHRND | CYP19A1 2393/4885MEN1 4141/4885KMT2A 4575/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.